Foghorn Therapeutics's total assets for Q1 2026 were $222.17M, an increase of 12.15% from the previous quarter. FHTX total liabilities were $298.57M for the fiscal quarter, a -2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.